Veerhealth Care's stock is currently priced at Rs. 23.85, marking an increase of 0.85 points or 3.70% from its previous close of Rs. 23.00 on the BSE.

The stock opened at Rs. 23.00 and fluctuated between a high of Rs. 24.00 and a low of Rs. 23.00. A total of 23,569 shares have been traded so far.

This BSE group 'X' stock, with a face value of Rs. 10, reached a 52-week high of Rs. 30.10 on February 23, 2024, and a 52-week low of Rs. 13.60 on December 13, 2023.

Over the past week, the stock’s high and low were Rs. 24.98 and Rs. 22.51, respectively. The company’s current market capitalization stands at Rs. 46.42 crore.

Promoters hold 30.41% of the company’s shares, while non-institutional investors hold 69.59%.

Veerhealth Care has acquired an additional 27,451 sq. ft. of land next to its current manufacturing site in Vapi, Gujarat. This expansion will facilitate the setup of new manufacturing lines compliant with CGMP norms required by USFDA to meet growing demand from the US market.

With this acquisition, the total plot area will expand to 58,623 sq. ft., combining the existing 31,172 sq. ft. with the new 27,451 sq. ft. The total constructed area will increase to 90,000 sq. ft., from the current 60,000 sq. ft. facility and the new 30,000 sq. ft. construction. The company anticipates significant demand and positive feedback from the US, East, and North African markets following the initial supply of oral care products. To meet this demand, Veerhealth Care plans to introduce high-capacity manufacturing and filling lines in the new facility.

The new facility will also feature plastic blow molding and injection molding machines, enabling the company to produce packing materials internally. This strategic move aims to offer a comprehensive solution to client needs and is expected to help Veerhealth Care achieve a revenue target of Rs 100 crore within the next 2 to 3 years with a 10% PAT margin. All manufacturing stages of the company's products will be completed within its own facilities.

Veerhealth Care is primarily involved in the trading, manufacturing, and marketing of research-based Ayurvedic medicines.